{"text": "TITLE:\n      The Protection Effect of Speeda\u00ae Rabies Vaccine for Human Use\nSUMMARY:\n      The objective of this study was to achieve the post-marketing protective effect research of\n      Speeda\u00ae rabies vaccine for human use from Chengda Bio.\nDETAILED DESCRIPTION:\n      When found the injury who is bitten by the animal to three-level, the investigators would\n      enroll the participant after explaining the protection and making him signed the informed\n      consent. The patient would inject rabies vaccine as follow the national regulation,\n      meanwhile the investigators would get the blood samples to detect whether the man-killer\n      carries the rabies virus.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Parent/legal acceptable representatives of children or the adult participants are\n             willing and able to understand the protocol requirements and provide informed consent\n             signed\n          -  Participant is considered to be in good health including the body and mental status\n             on the basis of reported medical history and limited physical examination and live in\n             local \u2265 12 months before injured\n          -  The man-killer could found and detect whether it carries the virus\n        Exclusion Criteria:\n          -  Known bleeding disorder or suspected impairment of immunologic function, or receipt\n             of immunosuppressive therapy or immunoglobulin since birth\n          -  Apply passive immunity preparation\n", "cuis": "C0034496 C1545588 C1947944 C1552616 C1706244 C0018017 C2239270 C2979883 C0947630 C0034496 C0678257 C0033080 C1521941 C3263723 C3540698 C1561610 C2090600 C1545588 C0562357 C0034496 C1156284 C3854058 C4049936 C0178913 C0442726 C0699809 C0034494 C0042769 C0243161 C0013893 C0243161 C0973449 C0162340 C0442711 C1507394 C1522729 C2348563 C3715209 C0600109 C0558080 C1299581 C1555587 C0009797 C0556050 C1561610 C2090600 C0278060 C0488568 C0488569 C2004284 C0152338 C3165543 C2019036 C2133562 C0031809 C0944752 C0946068 C2973270 C1444322 C1444324 C3834249 C4049609 C4049610 C4050368 C1561542 C0699809 C0442726 C0042769 C0243161 C0005779 C1458140 C0854145 C0455495 C0684336 C3845945 C2598156 C0031843 C1705273 C1521740 C0021079 C0455630 C0021027 C0020843 C0020852 C0202081 C0481219 C0085297 C0553533 C2748351 C0202083 C2825347 C0577612 C0202086 C0202087 C3536873 C0202084 C0201467 C0850992 C0005615 C1550722 C3245487 C0678210 C0071888 C0040165 C0041014 C0528271 C0608117 C0036679 ", "concepts": "Rabies Vaccine, Protection, Use summary, summary Objective, objective, Objective, study rabies vaccine description, prescription, prescription injury, animals signed, signed:, Protection, Uninformed rabies vaccine, ph regulation, donation, Donation blood samples, detect carries, rabies, virus criteria, Eligibility Criteria galega understand, Protocol, Protocol, Protocol, Protocol, Protocol, willing, Unwilling, able, provider, informed consent form, fat requirements signed, signed: mental status, Mental status, Mental status, Mental status, body, Participant ID, spouse in good health reported medical history, rnrx physical examination, Eye physical examination, Eye physical examination, Annual physical examination, Assess physical examination, Manage physical examination, Unlimited, Unlimited, Unlimited, Unlimited month carries, detect, virus Criteria bleeding disorders, Bleeding disorders, Feeding disorder, H/O: bleeding disorder, impairment, No impairment, Impairments, function, Function, Immunologics Immunosuppressive therapy, NOS, H/O: immunosuppressive therapy, immunoglobulins, Immunoglobulin D, Immunoglobulin G, Immunoglobulins, Immunoglobulin, IV immunoglobulin, low immunoglobulin, CSF immunoglobulin, Immunoglobulin A, Immunoglobulin A, Immunoglobulin D, Immunoglobulin E, Immunoglobulin G, Immunoglobulin G, Immunoglobulin M, immunoglobulin type, immunoglobulin test, births, birth, birth passive immunity, h preparation, T4 preparation, T3 preparation, preparation LB, preparation 31, Separation "}
